article thumbnail

OIG audit: Aetna may have raked in $25.5M in MA overpayments in 2015, 2016

Fierce Healthcare

million in overpayments from Medicare Advantage in 2015 and 2016. | million in overpayments from Medicare Advantage in 2015 and 2016. A new federal audit estimates that Aetna may have received at least $25.5 A new federal audit estimates that Aetna may have received at least $25.5

96
article thumbnail

U.N.: Progress on reducing global maternal mortality has stalled since 2015

STAT

The progress the world has made in reducing maternal mortality has stalled in recent years, with some regions — including Europe and Northern America — backsliding since 2015, according to a new report from United Nations agencies.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Evaluating Changes in Systemic Anticancer Therapy Use Between 2015 and 2019

Drug Topics

While the use of chemotherapy at end of life is decreasing, the use of immunotherapy is increasing.

article thumbnail

Biosimilars: Are They Delivering the Cost Savings Promised?

Pharmacy Times

Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.

FDA 152
article thumbnail

STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion

STAT

Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2022. Snapshot of our findings In 2015, women were underrepresented on staff and in management. The percentage of the entire staff who are people of color has doubled since 2015, growing from 15% to 31%.

110
110
article thumbnail

GARDASIL 9 Shows Positive Results in Phase 3 Study Against HPV-Related Cancers

Drug Topics

According to the Centers for Disease Control and Prevention, tens of thousands of HPV-related cancer diagnoses were given per year from 2015 to 2019.

98
article thumbnail

Todd Vasos returns as CEO of Dollar General

Drug Store News

Vasos, who previously served as Dollar General’s CEO from June 2015 to November 2022, is returning as CEO, succeeding Jeff Owen, whose separation from the company and resignation from its board is effective today.

105
105